Emerging peptide technologies , particularly those falling under the term "NXTGEN Peptides," present a intriguing paradigm change in clinical development. These cutting-edge strategies emphasize on engineering peptides with enhanced delivery, targeting, and efficacy – overcoming previous peptide-